Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001626947-24-000005
Filing Date
2024-07-02
Accepted
2024-07-02 12:34:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 CNSP_RF2.txt SC 13G 9179
  Complete submission text file 0001626947-24-000005.txt   10502
Mailing Address 54 DEEPDALE DR GREAT NECK NY 11021
Business Address
Forster Robert (Filed by) CIK: 0001626947 (see all company filings)

Type: SC 13G

Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185
CNS Pharmaceuticals, Inc. (Subject) CIK: 0001729427 (see all company filings)

EIN.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93973 | Film No.: 241093780
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)